1 Cyclosporin A (CsA) is a widely used compound because of its potent immunosupressive properties, derived mainly from the inhibition of calcineurin, and also because of its ability to block the mitochondrial permeability transition pore (PTP). This second effect has been involved in the protection against apoptosis mediated by release of mitochondrial factors. We show here that CsA (1-10mM) has an additional effect on Ca 2 þ homeostasis in mitochondria that cannot be attributed to inhibition of PTP. uniporter activator SB202190.
Introduction
Mitochondrial Ca 2 þ homeostasis is controlled by several mechanisms of Ca 2 þ transport present in the inner membrane of the organelle (Bernardi, 1999; Duchen, 2000; Rizzuto et al. , 2000) . The main pathway for Ca 2 þ influx into mitochondria is the Ca 2 þ uniporter, a specific and reversible Ca 2 þ transporter that under physiological conditions mediates entry of Ca 2 þ into mitochondria driven by the negative electrical potential of the matrix. This uniporter becomes activated only in the presence of micromolar concentrations of Ca 2 þ in the cytosolic side, and is therefore closed under resting conditions. The presence of a different mechanism, named rapid uptake mode, adapted to sequester Ca 2 þ from trains of physiological Ca 2 þ transients has also been suggested (Gunter et al., 1998) , although no direct evidence for this mechanism has been obtained in intact cells. Both the Ca 2 þ uniporter and the rapid uptake mode are inhibited by ruthenium red. Ca 2 þ exit from mitochondria is carried out by both a Na þ / Ca 2 þ exchanger and a H þ /Ca 2 þ exchanger, and under some conditions, by the opening of the permeability transition pore (PTP). This is a complex system whose molecular structure is still unclear and may include a series of constituents such as the voltage-dependent anion channel, the adenine nucleotide transporter, cyclophilin D and others (Bernardi, 1999; Crompton, 1999; Kim et al., 2003) . Cyclosporin A (CsA) is a well known and potent inhibitor of the PTP, producing full inhibition at concentrations in the submicromolar range (Bernardi et al., 1994) . It binds to cyclophilin D with high affinity and probably prevents its association with the adenine nucleotide transporter (Crompton, 1999) . However, this effect of CsA is not specific, and this compound affects other cellular processes, some of them also related to Ca 2 þ homeostasis. It is well known, for example, that immunosupression induced by CsA depends on the inhibition of calcineurin by complexes of CsA and cytosolic cyclophilins (Ivery, 2000; Matsuda & Koyasu, 2000) . This results in inhibition of Ca 2 þ -dependent signal transduction pathways in a range of cell types, including transcription of early response cytokines, such as IL-2, responsible for initiating the early proliferative signal in helper T cells. In addition, CsA may produce other effects probably via binding to different proteins of the family of the cyclophilins (Matsuda & Koyasu, 2000; Tran et al., 2000; Cristillo & Bierer, 2002) . Some of these effects appear at higher, micromolar, concentrations of CsA, and in some studies clearly different effects are obtained when low (submicromolar) or high (micromolar) concentrations of CsA are used (Griffiths et al., 2000) .
The aim of this study has been to test if some of these multiple effects of CsA could be explained by a direct action of this compound on mitochondrial Ca 2 þ uptake. We show here that micromolar concentrations of CsA inhibit Ca 2 þ entry into mitochondria through the Ca 2 þ uniporter, an effect that was not mimicked by other inhibitors of calcineurin. This effect is important because it may contribute to, or even mimic, some of the consequences of the direct inhibition of the PTP, such as inhibition of mitochondrial depolarization after stimulus or indirect inhibition of PTP opening due to reduced Ca 2 þ entry into mitochondria.
Methods

Cell culture and transfection
The construction strategy of the mutated mitochondrially targeted aequorin chimera has been described previously (Montero et al., 2000) . HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 5% fetal calf serum. The HeLa cell clone MM5, which stably expresses mitochondrially targeted mutated aequorin, has been described previously (Montero et al., 2002) . Similar data were obtained using wild-type cells transiently transfected with the mitmutAEQ/pcDNA3.1 plasmid. The construct for cytosolic aequorin has also been described previously (Montero et al., 2002) . It was cloned into the pcDNA3.1. plasmid and used to transfect wild-type HeLa cells. Transfections were carried out using Metafectene (Biontex, Munich, Germany).
The HeLa cell clone MM5 was used for [Ca 2 þ ] M measurements. [Ca 2 þ ] c measurements were carried out using HeLa cells transiently transfected with the plasmid for cytosolic aequorin. Cells were plated onto 13 mm round coverslips. For aequorin reconstitution, HeLa cells expressing cytosolic aequorin were incubated for 1-2 h at room temperature with 1 mM of wild-type coelenterazine, and cells expressing mitochondrially targeted mutated aequorin were incubated for 1-2 h at room temperature with either 1 mM of wild-type coelenterazine or 1 mM of coelenterazine n, in standard medium containing 145 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10 mM glucose and 10 mM HEPES, pH 7.4. Cells were then placed in the perfusion chamber of a purpose-built luminometer thermostatized at 371C. For the experiments with permeabilized cells, mitochondrially targeted mutated aequorin was reconstituted with coelenterazine n, in order to reduce its Ca 2 þ -affinity and allow measurement of higher [Ca 2 þ ] M . Then, standard medium containing 0.5 mM EGTA instead of Ca 2 þ was perfused for 1 min, followed by 1 min of intracellular medium (130 mM KCl, 10 mM NaCl, 1 mM MgCl 2 , 1 mM K 3 PO 4 , 0,5 mM EGTA, 1 mM ATP, 20 mM ADP, 2 mM succinate, 20 mM HEPES, pH 7) containing 100 mM digitonin. Then, intracellular medium without digitonin was perfused for 1 min, followed by buffers of known [Ca 2 þ ] between 2,5 and 10 mM, prepared in intracellular medium using HEDTA/Ca 2 þ /Mg 2 þ mixtures.
Materials
Wild-type coelenterazine and coelenterazine n were obtained from Molecular Probes (O, U.S.A. 
Statistical analysis
Averaged data are means 7 s.e.m. Analysis of variance (ANOVA) was applied to see differences between groups. The level of significance is indicated as: *, Po0.05; **, Po0.005; ***, Po 0.0005.
Results
We have studied the effects of CsA on both the mitochondrial and the cytosolic [Ca 2 þ ] transient induced by histamine in HeLa cells. Figure 1A shows that the [Ca 2 þ ] M transient was reduced in the presence of 10 mM CsA. In seven similar experiments, the [Ca 2 þ ] M peak in cells treated with CsA was 4676% (mean7s.e.m.) of the control peak. Instead, as shown in Figure 1B, Figure 4 shows the mean rates of uptake obtained in several experiments similar to those of 
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Finally, we compared the effect of the simultaneous treatment of the cells with CsA and with the activator of the mitochondrial Ca 2 þ uniporter SB202190. Figure 6 shows that SB202190 produced a large increase in the mitochondrial Ca 2 þ uptake, as previously reported (Montero et al., 2002) , and CsA reduced mitochondrial Ca 2 þ uptake, as shown above. Then, when both compounds were added together, Ca 2 þ uptake by mitochondria returned to be close to control values. SB202190 is a protein kinase inhibitor, apparently specific for p38 mitogen-associated protein kinase (Davies et al., 2000) . Thus, we have suggested that a protein kinase may constitutively be reducing the activity of the uniporter, so that in the presence of the inhibitor a phosphatase would reverse the effect and increase Ca 2 þ uptake (Montero et al., 2002) . However, the phosphatase activity of calcineurin was not involved in this process, as other inhibitors of calcineurin different from CsA, such as FK506 or cypermethrin, produced no significant effect on mitochondrial Ca 2 þ uptake in permeabilized cells. The rate of mitochondrial Ca 2 þ uptake was 10174% (mean7s.e.m, n ¼ 3) of the controls in the presence of 10 mM FK506, and 10877% (mean7s.e.m, n ¼ 6) of the controls in the presence of 2 mM cypermethrin. Similarly, other inhibitors of the PTP such as bongkrekic acid also produced no effect on [Ca 2 þ ] m uptake (the rate of uptake was 104711% (mean7s.e.m, n ¼ 6) of the controls in the presence of 5 mM bongkrekic acid), showing that inhibition of the PTP is neither involved in the inhibition of [Ca 2 þ ] m uptake by CsA.
Discussion
CsA is a cyclic undecapeptide that has been widely used in the treatment of allograft rejection and graft versus host disease because of its potent immunosuppresive properties. There is evidence that this effect relies mainly on the inhibition of calcineurin by a complex of CsA and cytosolic cyclophilins, although other mechanisms may also be involved (Ivery, 2000; Matsuda & Koyasu, 2000) . However, in spite of its efficacy for prevention of organ transplant rejection, the use of CsA as an immunosuppressant is limited by the presence of severe side effects including nephrotoxicity, neurotoxicity, hepatotoxicity and promotion of cancer progression (Matsuda & Koyasu, 2000) . These effects could depend on the action of CsA on other intracellular targets, such as the mitochondrial permeability transition pore PTP. Inhibition of PTP by CsA has been shown to prevent release of proapoptotic factors from mitochondria and so protect cells against apoptosis induced by different mechanisms. In fact, CsA is widely used today to Bernardi, 1998; Crompton, 1999; Duchen, 2000; Bernardi et al., 2001) . We show in this paper an additional effect of CsA on mitochondria, which is the inhibition of Ca 2 þ uptake through the Ca 2 þ uniporter. This transport system constitutes the main Ca 2 þ influx pathway of mitochondria and its activation is strongly dependent on the cytosolic [Ca 2 þ ] in the low micromolar range, which is the physiological range of [Ca 2 þ ] reached during cell stimulation. CsA shifts the curve of activation by Ca 2 þ of the uniporter to the right, reducing Ca 2 þ entry into mitochondria during [Ca 2 þ ] c transients. This effect cannot be explained by the inhibition of PTP, because this pathway can only mediate Ca 2 þ release from mitochondria and not Ca 2 þ influx. In fact, inhibition of PTP should increase mitochondrial membrane potential and reduce Ca 2 þ efflux from mitochondria, leading to increased levels of Ca 2 þ in mitochondria. On the other hand, the Ca 2 þ entry into mitochondria we measure is fully blocked by ruthenium red (Montero et al., 2000) , while the PTP is not sensitive to this compound (see Bernardi, 1999) , and a different inhibitor of PTP, bongkrekic acid, had no effect on Ca 2 þ entry. Finally, the inhibition of Ca 2 þ entry that we show in this paper occurs at micromolar concentrations of CsA, with an IC 50 around 1 mM, while inhibition by CsA of the PTP takes place at concentrations at least one order of magnitude lower (see Bernardi et al., 1994 and references therein) . As a conclusion, CsA inhibits Ca 2 þ entry by a mechanism clearly different than that responsible of inhibition of PTP. Regarding that mechanism, we show that CsA antagonized the effect of SB202190. This inhibitor of p38 mitogen-associated protein kinase strongly activates Ca 2 þ uptake by mitochondria at low [Ca 2 þ ] c (Montero et al., 2002) , an effect which is opposite to that found here for CsA. We reasoned that, if the effect of SB202190 was mediated by protein kinase inhibition, that of CsA could be mediated by inhibition of a phosphatase such as calcineurin. However, this was not the case, as the concentrations of CsA required to inhibit Ca 2 þ entry were higher than those necessary to block calcineurin, and other inhibitors of calcineurin, such as FK-506 or cypermethrin produced no effect on Ca 2 þ entry into mitochondria.
The new effect of CsA described here may be relevant to interpret some of the actions of this compound. Although inhibition of the PTP by CsA occurs at lower concentrations, most studies dealing with the effect of CsA on PTP use concentrations in the micromolar range (Ichas et al., 1997; Smaili et al., 2001; Brustovetsky et al., 2002; Levy et al., 2003) . Under these conditions, CsA may be acting both as PTP blocker and as inhibitor of Ca 2 þ entry. Interestingly, inhibition of Ca 2 þ entry would be expected to produce some effects similar to those of inhibition of PTP, for example, to reduce mitochondrial depolarization after cell stimulation (that induced by Ca 2 þ entry) and to inhibit indirectly the opening of PTP via a reduction in the [Ca 2 þ ] M levels. In contrast, direct inhibition of PTP should inhibit also mitochondrial depolarization (that induced by PTP opening), but should lead to an increase in the [Ca 2 þ ] M levels. This double effect of CsA, inhibition of PTP at low concentrations and of Ca 2 þ entry at higher concentrations, may be responsible for the discrepancies in the effects of CsA on [Ca 2 þ ] M found by different authors. It has been shown that low concentrations of CsA increased [Ca 2 þ ] M after reoxygenation injury of cardiomyocytes, while high doses reduced it (Griffiths et al., 2000) . In contrast, 5-10 mM CsA has been found to increase [Ca 2 þ ] m uptake and buffering (Smaili et al., 2001; Levy et al., 2003) . An additional factor that may contribute to these discrepancies is the [Ca 2 þ ] c dependence of the effect we show in this paper. 
